IVF earnings: next report 2026-08-13, real EPS beat/miss history, analyst consensus Buy, P/E -0.04. Updated 2026-07-23.
INVO Fertility (IVF) Research Hub
INVO Fertility (IVF) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-09-11, shares last closed at 0.9691 USD (+0.95%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.04, market cap 0.00B. This hub links to the full technical, earnings and options research available for IVF.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.9691 USD (+0.95%) |
| 52-week range | 0.9001 USD – 3.11 USD |
| Trend regime | Range |
| 14-day RSI | 46.4 (Neutral) |
| Trailing P/E | -0.04 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-13 |
Available research for IVF
Covered Call on IVF: how it works, illustrative setup around the real 0.9691 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on IVF: how it works, illustrative setup around the real 0.9691 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on IVF: how it works, illustrative setup around the real 0.9691 USD price, max profit/loss, breakeven and when to use it. Educational.
IVF technical analysis: range, last 0.9691 USD, RSI 46.4, 52w range 0.9001 USD–3.11 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is IVF in?
INVO Fertility (IVF) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is IVF in an uptrend or downtrend?
As of 2026-09-11, IVF is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is IVF's trailing P/E ratio?
IVF's trailing P/E is -0.04, with a market cap of 0.00B. See the earnings research page for full valuation detail.
When does IVF next report earnings?
IVF is next scheduled to report earnings on 2026-08-13, with a consensus EPS estimate of -0.7 USD.